The Effect of Phosphodiesterase Type 5 Inhibitors on the Development of Retinopathy of Prematurity in Imam Khomeini Hospital's, Ahvaz, Iran Preterm Infants: A Randomized Clinical Trial
Masoud Dehdashtian, Mostafa Feghhi, Mohammad Reza Aramesh, Arash Malakian, Mohammad Reza Abbaspour, Seyed Mohammad Hassan Altayeb & Ali Khosrevi · Journal of Pharmaceutical Research International · 2019
Background: Retinopathy of prematurity (ROP) affects premature infants, and it is characterized by the development of vascular proliferation due to hyperoxia, down regulation of Vascular endothelial growth factor(VEGF) and death of endothelial cells. We hypothesized that inhibiti...
Open access
Research Article
10.9734/jpri/2019/v28i530214